ABM Industries Incorporated (NYSE:ABM) will release earnings results for the fourth quarter before the opening bell on Wednesday, Dec. 17. Analysts expect the New York-based company to report quarterly earnings at $1.09 per share, up from 90 cents per share…
Gilead Sciences Inc. (NASDAQ:GILD) on Monday shared topline results from the Phase 3 ARTISTRY-2 trial. The trial evaluated the treatment responses of adults with HIV who are virologically suppressed, switching from Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide, B/F/TAF) to a fixed-dose combination of…
Immunome Inc. (NASDAQ:IMNM) stock rose Monday, with session volume surging to 8.25 million shares, well above the stock’s average daily volume of 1.50 million, according to Benzinga Pro data. Immunome on Monday shared topline results from the global pivotal Phase…
Alphabet Inc (NASDAQ:GOOGL)(NASDAQ:GOOG) could be heading for another earnings tailwind — and investors in ETFs may feel this before they realize why. • Alphabet is in focus. Check its prices, live. SpaceX, a closely held rocket and satellite technology firm…
Gainers Netclass Technology (NASDAQ:NTCL) shares rose 32.6% to $0.9 during Monday's regular session. The market value of their outstanding shares is at $14.9 million. 1-800-Flowers.com (NASDAQ:FLWS) stock increased by 14.45% to $4.47. The company's market cap stands at $248.9 million.…
Luminar Technologies, Inc. (NASDAQ:LAZR) shares are under heavy pressure Monday after the company announced that it initiated voluntary Chapter 11 proceedings to pursue court-supervised sale processes for its core businesses. Luminar Technologies shares are approaching critical lows. What’s pressuring LAZR? What To Know:…
Eli Lilly & Co. (NYSE:LLY)'s dominance in obesity therapeutics looks increasingly difficult to challenge, and Bank of America believes the market is still underestimating just how much growth lies ahead. On Monday, the bank’s analyst Jason Gerberry reiterated a Buy…
Deep-pocketed investors have adopted a bullish approach towards Carvana (NYSE:CVNA), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a…
Financial giants have made a conspicuous bearish move on Merck & Co. Our analysis of options history for Merck & Co (NYSE:MRK) revealed 17 unusual trades. Delving into the details, we found 35% of traders were bullish, while 41% showed…
In the current session, the stock is trading at $683.87, after a 1.97% increase. Over the past month, AppLovin Inc. (NASDAQ:APP) stock increased by 30.01%, and in the past year, by 102.39%. With performance like this, long-term shareholders are optimistic…